Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients

Hung Tien Kuo, Edmund Huang, Sina Emami, Phuong Thu Pham, Alan H. Wilkinson, Gabriel M. Danovitch, Suphamai Bunnapradist

Research output: Contribution to journalArticle

Abstract

BACKGROUND.: We aimed to investigate the impact of antibody induction on outcomes in human leukocyte antigen (HLA) 0-mismatched deceased donor kidney recipients. METHODS.: Using the Organ Procurement and Transplant Network/United Network of Organ Sharing database as of November 2009, we identified 44,008 adult deceased donor kidney recipients who received primary kidney transplants alone between 2003 and 2008 (HLA 0 mismatch, n=6274; ≥1 mismatch, n=37,734; median follow-up: 834 days). The impact of induction (thymoglobulin, interleukin-2 receptor antagonists [IL-2RA], or alemtuzumab; vs. no induction) on rejection (initial hospitalization, 6 months, first year), death-censored graft failure, and mortality were analyzed using multivariate logistic and Cox regression in the two groups. The impact of individual agents on outcomes was further analyzed in 0-mismatch recipients. RESULTS.: There was a decreased risk of rejection over the first 6 months for HLA 0-mismatch recipients of antibody induction (adjusted odds ratio=0.71, P=0.003), but this effect was not observed at 1 year; in comparison, induction was associated with a reduced risk of rejection over the first year for HLA-mismatched recipients (0.87, P

Original languageEnglish (US)
Pages (from-to)493-502
Number of pages10
JournalTransplantation
Volume93
Issue number5
DOIs
StatePublished - Mar 15 2012
Externally publishedYes

Fingerprint

HLA Antigens
Transplants
Kidney
Antibodies
Tissue and Organ Procurement
Interleukin-2 Receptors
Hospitalization
Logistic Models
Odds Ratio
Databases
Mortality

Keywords

  • Induction
  • Kidney transplant
  • Outcomes
  • Zero HLA mismatch

ASJC Scopus subject areas

  • Transplantation

Cite this

Kuo, H. T., Huang, E., Emami, S., Pham, P. T., Wilkinson, A. H., Danovitch, G. M., & Bunnapradist, S. (2012). Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Transplantation, 93(5), 493-502. https://doi.org/10.1097/TP.0b013e3182427fc3

Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. / Kuo, Hung Tien; Huang, Edmund; Emami, Sina; Pham, Phuong Thu; Wilkinson, Alan H.; Danovitch, Gabriel M.; Bunnapradist, Suphamai.

In: Transplantation, Vol. 93, No. 5, 15.03.2012, p. 493-502.

Research output: Contribution to journalArticle

Kuo, HT, Huang, E, Emami, S, Pham, PT, Wilkinson, AH, Danovitch, GM & Bunnapradist, S 2012, 'Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients', Transplantation, vol. 93, no. 5, pp. 493-502. https://doi.org/10.1097/TP.0b013e3182427fc3
Kuo, Hung Tien ; Huang, Edmund ; Emami, Sina ; Pham, Phuong Thu ; Wilkinson, Alan H. ; Danovitch, Gabriel M. ; Bunnapradist, Suphamai. / Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. In: Transplantation. 2012 ; Vol. 93, No. 5. pp. 493-502.
@article{457180aa4c7c4ac8a0497b0774a72ee6,
title = "Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients",
abstract = "BACKGROUND.: We aimed to investigate the impact of antibody induction on outcomes in human leukocyte antigen (HLA) 0-mismatched deceased donor kidney recipients. METHODS.: Using the Organ Procurement and Transplant Network/United Network of Organ Sharing database as of November 2009, we identified 44,008 adult deceased donor kidney recipients who received primary kidney transplants alone between 2003 and 2008 (HLA 0 mismatch, n=6274; ≥1 mismatch, n=37,734; median follow-up: 834 days). The impact of induction (thymoglobulin, interleukin-2 receptor antagonists [IL-2RA], or alemtuzumab; vs. no induction) on rejection (initial hospitalization, 6 months, first year), death-censored graft failure, and mortality were analyzed using multivariate logistic and Cox regression in the two groups. The impact of individual agents on outcomes was further analyzed in 0-mismatch recipients. RESULTS.: There was a decreased risk of rejection over the first 6 months for HLA 0-mismatch recipients of antibody induction (adjusted odds ratio=0.71, P=0.003), but this effect was not observed at 1 year; in comparison, induction was associated with a reduced risk of rejection over the first year for HLA-mismatched recipients (0.87, P",
keywords = "Induction, Kidney transplant, Outcomes, Zero HLA mismatch",
author = "Kuo, {Hung Tien} and Edmund Huang and Sina Emami and Pham, {Phuong Thu} and Wilkinson, {Alan H.} and Danovitch, {Gabriel M.} and Suphamai Bunnapradist",
year = "2012",
month = "3",
day = "15",
doi = "10.1097/TP.0b013e3182427fc3",
language = "English (US)",
volume = "93",
pages = "493--502",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients

AU - Kuo, Hung Tien

AU - Huang, Edmund

AU - Emami, Sina

AU - Pham, Phuong Thu

AU - Wilkinson, Alan H.

AU - Danovitch, Gabriel M.

AU - Bunnapradist, Suphamai

PY - 2012/3/15

Y1 - 2012/3/15

N2 - BACKGROUND.: We aimed to investigate the impact of antibody induction on outcomes in human leukocyte antigen (HLA) 0-mismatched deceased donor kidney recipients. METHODS.: Using the Organ Procurement and Transplant Network/United Network of Organ Sharing database as of November 2009, we identified 44,008 adult deceased donor kidney recipients who received primary kidney transplants alone between 2003 and 2008 (HLA 0 mismatch, n=6274; ≥1 mismatch, n=37,734; median follow-up: 834 days). The impact of induction (thymoglobulin, interleukin-2 receptor antagonists [IL-2RA], or alemtuzumab; vs. no induction) on rejection (initial hospitalization, 6 months, first year), death-censored graft failure, and mortality were analyzed using multivariate logistic and Cox regression in the two groups. The impact of individual agents on outcomes was further analyzed in 0-mismatch recipients. RESULTS.: There was a decreased risk of rejection over the first 6 months for HLA 0-mismatch recipients of antibody induction (adjusted odds ratio=0.71, P=0.003), but this effect was not observed at 1 year; in comparison, induction was associated with a reduced risk of rejection over the first year for HLA-mismatched recipients (0.87, P

AB - BACKGROUND.: We aimed to investigate the impact of antibody induction on outcomes in human leukocyte antigen (HLA) 0-mismatched deceased donor kidney recipients. METHODS.: Using the Organ Procurement and Transplant Network/United Network of Organ Sharing database as of November 2009, we identified 44,008 adult deceased donor kidney recipients who received primary kidney transplants alone between 2003 and 2008 (HLA 0 mismatch, n=6274; ≥1 mismatch, n=37,734; median follow-up: 834 days). The impact of induction (thymoglobulin, interleukin-2 receptor antagonists [IL-2RA], or alemtuzumab; vs. no induction) on rejection (initial hospitalization, 6 months, first year), death-censored graft failure, and mortality were analyzed using multivariate logistic and Cox regression in the two groups. The impact of individual agents on outcomes was further analyzed in 0-mismatch recipients. RESULTS.: There was a decreased risk of rejection over the first 6 months for HLA 0-mismatch recipients of antibody induction (adjusted odds ratio=0.71, P=0.003), but this effect was not observed at 1 year; in comparison, induction was associated with a reduced risk of rejection over the first year for HLA-mismatched recipients (0.87, P

KW - Induction

KW - Kidney transplant

KW - Outcomes

KW - Zero HLA mismatch

UR - http://www.scopus.com/inward/record.url?scp=84857655507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857655507&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3182427fc3

DO - 10.1097/TP.0b013e3182427fc3

M3 - Article

C2 - 22306574

AN - SCOPUS:84857655507

VL - 93

SP - 493

EP - 502

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -